In vivo experiments also showed that knockdown of SNHG12 significantly inhibited xenograft tumour growth, and co‐silencing of SNHG12 and miR‐30a‐3p partially compromised the tumour growth. This evidence concerns the gene SNHG12 and neoplasm.